After Cardiac Surgery,How Does Nutrition Fit in With Risk Factors?

Abstract

Get full access to this article

View all access options for this article.

References

Olendzki

. Dietary quality 1 year after diagnosis of coronary heart disease. J Am Diet Assoc. 2008;108:240-246.

Hartwell

Henry

. Dietary advice for patients undergoing coronary artery bypass surgery: falling on deaf ears? Int J Food Sci Nutr. 2003;54:37-47.

Pierson

Norton

Herbert

. Recovery of self-reported functional capacity after coronary artery bypass surgery. Chest. 2003;123:1367-1374.

Miller

Pierson

. Changes in bone mineral and body composition following coronary artery bypass grafting in men. Am J Cardiol. 2007;99:585-587.

Aquilani

Opasich

Verri

. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol. 2003;42:1218-1223.

Alsafwah

LaGuardia

Arroyo

. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res. 2008;5:238-243.

Racca

Castiglioni

Ripamonti

. Nutritional markers in patients after heart surgery. JPEN J Parenter Enteral Nutr. 2010;34:143-150.

Han

Truesdale

Taber

. Impact of overweight and obesity on hospitalization: race and gender differences. Int J Obes. 2009;33:249-256.

Ruyun

Gary

Grunkemeier

. Is obesity a risk factor for mortality in coronary artery bypass surgery? Circulation. 2005;111:3359-3365.

10.

Wigfield

Lindsey

Munoz

. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI≥40. Eur J Cardiothorac Surg. 2006;29:434-440.

11.

Echahidi

Mohty

Pibarot

. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation. 2007;116:I213-I219.

12.

Ridker

Danielson

Fonseca

. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.

13.

Gerstein

Miller

Byington

. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.

14.

Patel

MacMahon

Chalmers

. ADVANCE Collaborative Group. Intensive glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.

15.

Duckworth

Abraira

Moritz

. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.

16.

Havas

. The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom. Arch Intern Med. 2009;169:150-154.

17.

Skyler

Bergenstal

Bonow

. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119:351-357.

18.

Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.

19.

Colhoun

Betteridge

Durrington

. CARDS Investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685-696.

20.

Van den Berghe

Wouters

Weekers

. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.

21.

Wiener

Larson

. Benefits and risks of tight glucose control in critically ill adults. A meta-analysis. JAMA. 2008;300:933-944.

22.

Balasubramanyam

. Intensive glycemic control in the intensive care unit: promises and pitfalls. J Clin Endocrinol Metab. 2009;94:416-417.

23.

Nigro

Osman

Dart

. Insulin resistance and atherosclerosis. Endocr Rev. 2006;27:242-259.

24.

Gustafson

Hammarstedt

Andersson

. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2276-2283.

25.

Bhatt

. Anti-inflammatory agents and antioxidants as a possible “Third Great Wave” in cardiovascular secondary prevention. Am J Cardiol. 2008;101(suppl):4D-13D.

26.

de Ferranti

Mozaffarian

. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945-955.

27.

Cave

Hurt

Frazier

. Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract. 2008;23:16-34.

28.

Mathieu

Poirier

Pibarot

. Visceral obesity; the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53(4):577-584.

29.

Collier

Dossett

May

. Glucose control and the inflammatory response. Nutr Clin Pract. 2008;23:3-15.

30.

Ceriello

Ihnat

Thorpe

. The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94:410-415.

31.

Hlatky

. Expanding the orbit of primary prevention—moving beyond JUPITER. N Engl J Med. 2008;359:2280-2282.

32.

Fuster

Bansilal

. JUPITER strikes earth. Nat Clin Pract Cardiovasc Med. 2009;6:159.

33.

Kushner

Rzewnicki

Samols

. What does minor elevation of C-reactive protein signify? Am J Med. 2006;119:166.e17-166.e28.

34.

Musunuru

Kral

Blumenthal

. The use of high-sensitivity assays for c-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;621-635.

35.

Scheurig

Thorand

Fischer

. Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. Eur J Clin Nutr. 2008;62:127-137.

36.

Jensen

. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. JPEN J Parenter Enteral Nutr. 2006;30:453-463.

37.

Elliott

. Too many pills exacerbate perils of aging. American Medical News, March 26, 2007. http://www.ama-assn.org/amednews/2007/03/26/hll20326.htm Accessed February 20, 2009.

38.

Steinman

Landefeld

Rosenthal

. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516-1523.

39.

Mallet

Spinewine

Huang

. Prescribing in elderly people 2: the challenge of managing drug interactions in elderly people. Lancet. 2007;370:185-191.

40.

Hohl

Robitaille

Lord

. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med. 2005;12:197-205.

41.

Ming

Davidson

Gandhi

. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases. J Clin Lipidol. 2008;2:453-463.

42.

Charlson

Isom

. Care after coronary-artery bypass surgery. N Engl J Med. 2003;348:1456-1463.

43.

Eagle

Guyton

Davidoff

. Coronary artery bypass graft surgery. ACC/AHA Pocket Guideline. Washington, DC and Dallas, TX: American College of Cardiology Foundation and American Heart Association Inc; 2005:40-43, 60-64. http://www.acc.org/qualityandscience/clinical/guidelines/CABG/index_pkt.pdf .

44.

Liakopoulos

Choi

Y-H

Haldenwang

. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548-1559.

45.

Shah

Waters

Barter

. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol. 2008;51:1938-1943.

46.

Domanski

Tian

Fleg

. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary bypass graft (post CABG) Trial. Am J Cardiol. 2008;102:1023-1027.

47.

Gibbs

Cull

Henderson

. Preoperative serum albumin level as a predictor of operative mortality and morbidity. Arch Surg. 1999;134:36-42.

48.

Rady

Ryan

Starr

. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. JPEN J Parenter Enteral Nutr. 1997;21:81-90.

49.

Rapp-Kesek

Stahle

Karlsson

. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr. 2004;23:1398-1404.

50.

Boldt

Brosch

Rohm

. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg. 2008;107:1496-1503.

51.

Allen

. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89(suppl):693S-696S.

52.

Serraj

Vogel

Federici

. Syndrome de non-dissociation de la vitamine B12 de ses proteins porteuses ou de maldigestion des cobalamines alimentaires. Press Med. 2009;38:55-62.

53.

Green

. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull. 2008;29(suppl 2):S52-S63.

54.

Ting

RZ-W

Szeto

Chan

MH-M

. Risk factors of vitamin B12 deficiency in patients receiving metformin. Arch Intern Med. 2006;166:1975-1979.

55.

Green

Miller

. Vitamin B12 deficiency is the dominant nutritional cause of hyper-homocysteinemia in a folic acid-fortified population. Clin Chem Lab Med. 2005;43:1048-1051.

56.

Abiles

Abud

Moratalla

. High prevalence of hyperhomocysteinemia in critically ill patients: vascular damage and adequate vitamin intake. Eur eJournal Clin Nutr Metab. 2008;3:e240-e245.

57.

Rodionov

Lentz

. The homocysteine paradox. Arterioscler Throm Vasc Biol. 2008;28:1031-1033.

58.

Antoniades

Antonopoulos

Tousoulis

. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6-15.

59.

Maron

Loscalzo

. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009;60:39-54.

60.

Schnyder

Roffi

Flammer

. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. The Swiss Heart Study: a randomized controlled trial. JAMA. 2002;288:973-979.